Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE

Who can take part

• Be a female diagnosed with endometrial cancer and scheduled for UAE
• Be over the age of 18 years
• If the subject is of child-bearing potential, must have a negative pregnancy test
• Be conscious and able to comply with study procedures
• Have read and signed the IRB approved consent form for participating in the study

Who cannot take part

• Patients who have received an investigational drug in the 30 days before study drug administration, or will receive one within 72 hours afterwards
• Patients who have undergone surgery within 24 hours prior to the study sonographic examination
• Patients with clinically unstable cardiac arrhythmias, such as recurrent ventricular tachycardia
• Patients with recent cerebral hemorrhage
• Patients with congenital heart defects
• Patient with a known allergy to Definity
• Females who are pregnant or nursing
• Patients who are medically unstable, patients who are seriously or terminally ill, and patients whose clinical course is unpredictable. For example:
• Patients on life support or in a critical care unit